About Ohio State University, Department of Neurology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Ohio State University, Department of Neurology
During the past decade, Ohio State University, Department of Neurology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on
average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Ohio State University, Department of Neurology" #1 sponsor was "Cytokinetics" with 2 trials, followed by "Genentech, Inc." with 2 trials
sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "University of Utah" with 2 trials sponsored and "Children's Hospital of Philadelphia"
with 2 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ohio State University, Department of Neurology"
#1 collaborator was "Families of Spinal Muscular Atrophy" with 2 trials as a collaborator, "Friedreich's Ataxia Research Alliance" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at Ohio State University, Department of Neurology
According to Clinical.Site data, the most researched conditions in "Ohio State University, Department of Neurology" are
"Amyotrophic Lateral Sclerosis" (2 trials), "Friedreich Ataxia" (2 trials), "Alzheimer's Disease" (1 trials), "Dementia" (1 trials) and "Generalized Myasthenia Gravis" (1 trials). Many other conditions were trialed in "Ohio State University, Department of Neurology" in a lesser frequency.
Clinical Trials Intervention Types at Ohio State University, Department of Neurology
Most popular intervention types in "Ohio State University, Department of Neurology" are "Drug" (11 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Ocrelizumab" (3 trials), "CK-2017357" (2 trials), "Droxidopa capsules" (1 trials) and "Omaveloxolone Capsules, 10 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Ohio State University, Department of Neurology
The vast majority of trials in "Ohio State University, Department of Neurology" are
12 trials for "All" genders.
Clinical Trials Status at Ohio State University, Department of Neurology
Currently, there are NaN active trials in "Ohio State University, Department of Neurology".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Ohio State University, Department of Neurology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Ohio State University, Department of Neurology, 1 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".